Voyager Therapeutics, Inc. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
Voyager Therapeutics, Inc. (VYGR) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $1.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2017-11-02
- 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $1.00K.
- 2017-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $260.00K.
- 2017-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $780.00K.
- 2016-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $142.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2017-09-30 | $1.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $260.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $780.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $142.00K 10-Q · filed 2017-11-02 |
| 2016-09-30 | $1.20M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $60.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $33.00K 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |